The effects of orally administered Bacillus coagulans and inulin on prevention and progression of rheumatoid arthritis in rats
Probiotics have been considered as an approach to addressing the consequences of different inflammatory disorders. The spore-forming probiotic strain Bacillus coagulans has demonstrated anti-inflammatory and immune-modulating effects in both animals and humans. The prebiotic inulin also potentially...
Gespeichert in:
Veröffentlicht in: | Food & nutrition research 2016-01, Vol.60 (1), p.30876-30876 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 30876 |
---|---|
container_issue | 1 |
container_start_page | 30876 |
container_title | Food & nutrition research |
container_volume | 60 |
creator | Abhari, Khadijeh Shekarforoush, Seyed Shahram Hosseinzadeh, Saeid Nazifi, Saeid Sajedianfard, Javad Eskandari, Mohammad Hadi |
description | Probiotics have been considered as an approach to addressing the consequences of different inflammatory disorders. The spore-forming probiotic strain Bacillus coagulans has demonstrated anti-inflammatory and immune-modulating effects in both animals and humans. The prebiotic inulin also potentially affects the immune system as a result of the change in the composition or fermentation profile of the gastrointestinal microbiota.
In the present study, an in vivo model was conducted to investigate the possible influences of probiotic B. coagulans and prebiotic inulin, both in combination and/or separately, on the downregulation of immune responses and the progression of rheumatoid arthritis (RA), using arthritis-induced rat model.
Forty-eight healthy male Wistar rats were randomly categorized into six experimental groups as follows: 1) control: normal healthy rats fed with standard diet, 2) disease control (RA): arthritis-induced rats fed with standard diet, 3) prebiotic (PRE): RA+ 5% w/w long-chain inulin, 4) probiotic (PRO): RA+ 10
9
spores/day B. coagulans by orogastric gavage, 5) synbiotic (SYN): RA+ 5% w/w long-chain inulin and 10
9
spores/day B. coagulans, and 6) treatment control: (INDO): RA+ 3 mg/kg/day indomethacin by orogastric gavage. Feeding with the listed diets started on day 0 and continued to the end of study. On day 14, rats were injected with complete Freund's adjuvant (CFA) to induce arthritis. Arthritis activity was evaluated by the biochemical parameters and paw thickness. Biochemical assay for fibrinogen (Fn), serum amyloid A (SAA), and TNF-α and alpha-1-acid glycoprotein (α
1
AGp) was performed on day 21, 28, and 35 (7, 14 and 21 days post RA induction), respectively.
Pretreatment with PRE, PRO, and SYN diets significantly inhibits SAA and Fn production in arthritic rats (P < 0.001). A significant decrease in the production of pro-inflammatory cytokines, such as TNF-α, was seen in the PRE, PRO, and SYN groups (P < 0.001), which was similar to the anti-inflammatory effect of indomethacin. Furthermore, no significant anti-inflammatory effects were observed following different treatments using α
1
AGp as an RA indicator. Pretreatment with all supplied diets significantly inhibited the development of paw swelling induced by CFA (P < 0.001).
The results of this study indicate that the oral intake of probiotic B. coagulans and prebiotic inulin can improve the biochemical and clinical parameters of induced RA in rat. |
doi_str_mv | 10.3402/fnr.v60.30876 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_3402_fnr_v60_30876</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_6059db148f3a452b8a273e39252ae90d</doaj_id><sourcerecordid>2215233966</sourcerecordid><originalsourceid>FETCH-LOGICAL-c491t-fec32ef84d7fe454bab999127717a3bc0f16ea909da7dd02132d50a5680cc09e3</originalsourceid><addsrcrecordid>eNptkkuLFDEURgtRnHF06VYCbtzUmFcllY2gg4-BATcjuAu38uhOU5W0SVVLb_ztpqfHxhFXuUlODjeXr2leEnzJOKZvfcyXO1E3uJfiUXNORMdbIcj3x6ea9mfNs1I2GItK8afNGZWcSqL4efPrdu2Q896ZuaDkUcowjnsEdgoxlNllZ9EHMGEcl4JMgtUyQiwIokUhLmOIKEW0zW7n4hxqebjY5rTKrpTDvirz2i0TzClYBHle5zCHUh-jDHN53jzxMBb34n69aL59-nh79aW9-fr5-ur9TWu4InNb22PU-Z5b6R3v-ACDUopQKYkENhjsiXCgsLIgrcWUMGo7DJ3osTFYOXbRXB-9NsFGb3OYIO91gqDvDlJe6dpbMKPTAnfKDoT3ngHv6NADlcwxRTsKTmFbXe-Oru0yTM6a-vM6tAfShzcxrPUq7TRXXPaMV8Gbe0FOPxZXZj2FYtxYJ-vSUjTpccd7IaWq6Ot_0E1acqyj0pSSjjKmhKhUe6RMTqVk50_NEKwPKdE1JbqmRN-lpPKv_v7Bif4Tiwr0RyBEn_IEP1MerZ5hP6bsM0QTimb_d_8G0D_PJg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2215233966</pqid></control><display><type>article</type><title>The effects of orally administered Bacillus coagulans and inulin on prevention and progression of rheumatoid arthritis in rats</title><source>Taylor & Francis Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Co-Action Open Access Journals</source><source>Norart Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Abhari, Khadijeh ; Shekarforoush, Seyed Shahram ; Hosseinzadeh, Saeid ; Nazifi, Saeid ; Sajedianfard, Javad ; Eskandari, Mohammad Hadi</creator><creatorcontrib>Abhari, Khadijeh ; Shekarforoush, Seyed Shahram ; Hosseinzadeh, Saeid ; Nazifi, Saeid ; Sajedianfard, Javad ; Eskandari, Mohammad Hadi</creatorcontrib><description>Probiotics have been considered as an approach to addressing the consequences of different inflammatory disorders. The spore-forming probiotic strain Bacillus coagulans has demonstrated anti-inflammatory and immune-modulating effects in both animals and humans. The prebiotic inulin also potentially affects the immune system as a result of the change in the composition or fermentation profile of the gastrointestinal microbiota.
In the present study, an in vivo model was conducted to investigate the possible influences of probiotic B. coagulans and prebiotic inulin, both in combination and/or separately, on the downregulation of immune responses and the progression of rheumatoid arthritis (RA), using arthritis-induced rat model.
Forty-eight healthy male Wistar rats were randomly categorized into six experimental groups as follows: 1) control: normal healthy rats fed with standard diet, 2) disease control (RA): arthritis-induced rats fed with standard diet, 3) prebiotic (PRE): RA+ 5% w/w long-chain inulin, 4) probiotic (PRO): RA+ 10
9
spores/day B. coagulans by orogastric gavage, 5) synbiotic (SYN): RA+ 5% w/w long-chain inulin and 10
9
spores/day B. coagulans, and 6) treatment control: (INDO): RA+ 3 mg/kg/day indomethacin by orogastric gavage. Feeding with the listed diets started on day 0 and continued to the end of study. On day 14, rats were injected with complete Freund's adjuvant (CFA) to induce arthritis. Arthritis activity was evaluated by the biochemical parameters and paw thickness. Biochemical assay for fibrinogen (Fn), serum amyloid A (SAA), and TNF-α and alpha-1-acid glycoprotein (α
1
AGp) was performed on day 21, 28, and 35 (7, 14 and 21 days post RA induction), respectively.
Pretreatment with PRE, PRO, and SYN diets significantly inhibits SAA and Fn production in arthritic rats (P < 0.001). A significant decrease in the production of pro-inflammatory cytokines, such as TNF-α, was seen in the PRE, PRO, and SYN groups (P < 0.001), which was similar to the anti-inflammatory effect of indomethacin. Furthermore, no significant anti-inflammatory effects were observed following different treatments using α
1
AGp as an RA indicator. Pretreatment with all supplied diets significantly inhibited the development of paw swelling induced by CFA (P < 0.001).
The results of this study indicate that the oral intake of probiotic B. coagulans and prebiotic inulin can improve the biochemical and clinical parameters of induced RA in rat.</description><identifier>ISSN: 1654-6628</identifier><identifier>ISSN: 1654-661X</identifier><identifier>EISSN: 1654-661X</identifier><identifier>DOI: 10.3402/fnr.v60.30876</identifier><identifier>PMID: 27427194</identifier><language>eng</language><publisher>Sweden: Taylor & Francis</publisher><subject>Amyloid ; animal model ; Arthritis ; Bacillus coagulans ; Biochemistry ; Chains ; Cytokines ; Diet ; Disease control ; Fermentation ; Fibrinogen ; Freund's adjuvant ; Glycoproteins ; Immune response ; Immune system ; Immunomodulation ; In vivo methods and tests ; Indomethacin ; Inflammatory diseases ; Inulin ; Mathematical models ; Microbiota ; Oral administration ; Original ; Parameters ; Prebiotics ; Pretreatment ; Probiotics ; Rheumatoid arthritis ; Rodents ; Spores ; Tumor necrosis factor-α</subject><ispartof>Food & nutrition research, 2016-01, Vol.60 (1), p.30876-30876</ispartof><rights>2016 Khadijeh Abhari et al. 2016</rights><rights>2016 Khadijeh Abhari et al. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c491t-fec32ef84d7fe454bab999127717a3bc0f16ea909da7dd02132d50a5680cc09e3</citedby><cites>FETCH-LOGICAL-c491t-fec32ef84d7fe454bab999127717a3bc0f16ea909da7dd02132d50a5680cc09e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947834/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947834/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,4139,27502,27924,27925,53791,53793,59143,59144</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27427194$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abhari, Khadijeh</creatorcontrib><creatorcontrib>Shekarforoush, Seyed Shahram</creatorcontrib><creatorcontrib>Hosseinzadeh, Saeid</creatorcontrib><creatorcontrib>Nazifi, Saeid</creatorcontrib><creatorcontrib>Sajedianfard, Javad</creatorcontrib><creatorcontrib>Eskandari, Mohammad Hadi</creatorcontrib><title>The effects of orally administered Bacillus coagulans and inulin on prevention and progression of rheumatoid arthritis in rats</title><title>Food & nutrition research</title><addtitle>Food Nutr Res</addtitle><description>Probiotics have been considered as an approach to addressing the consequences of different inflammatory disorders. The spore-forming probiotic strain Bacillus coagulans has demonstrated anti-inflammatory and immune-modulating effects in both animals and humans. The prebiotic inulin also potentially affects the immune system as a result of the change in the composition or fermentation profile of the gastrointestinal microbiota.
In the present study, an in vivo model was conducted to investigate the possible influences of probiotic B. coagulans and prebiotic inulin, both in combination and/or separately, on the downregulation of immune responses and the progression of rheumatoid arthritis (RA), using arthritis-induced rat model.
Forty-eight healthy male Wistar rats were randomly categorized into six experimental groups as follows: 1) control: normal healthy rats fed with standard diet, 2) disease control (RA): arthritis-induced rats fed with standard diet, 3) prebiotic (PRE): RA+ 5% w/w long-chain inulin, 4) probiotic (PRO): RA+ 10
9
spores/day B. coagulans by orogastric gavage, 5) synbiotic (SYN): RA+ 5% w/w long-chain inulin and 10
9
spores/day B. coagulans, and 6) treatment control: (INDO): RA+ 3 mg/kg/day indomethacin by orogastric gavage. Feeding with the listed diets started on day 0 and continued to the end of study. On day 14, rats were injected with complete Freund's adjuvant (CFA) to induce arthritis. Arthritis activity was evaluated by the biochemical parameters and paw thickness. Biochemical assay for fibrinogen (Fn), serum amyloid A (SAA), and TNF-α and alpha-1-acid glycoprotein (α
1
AGp) was performed on day 21, 28, and 35 (7, 14 and 21 days post RA induction), respectively.
Pretreatment with PRE, PRO, and SYN diets significantly inhibits SAA and Fn production in arthritic rats (P < 0.001). A significant decrease in the production of pro-inflammatory cytokines, such as TNF-α, was seen in the PRE, PRO, and SYN groups (P < 0.001), which was similar to the anti-inflammatory effect of indomethacin. Furthermore, no significant anti-inflammatory effects were observed following different treatments using α
1
AGp as an RA indicator. Pretreatment with all supplied diets significantly inhibited the development of paw swelling induced by CFA (P < 0.001).
The results of this study indicate that the oral intake of probiotic B. coagulans and prebiotic inulin can improve the biochemical and clinical parameters of induced RA in rat.</description><subject>Amyloid</subject><subject>animal model</subject><subject>Arthritis</subject><subject>Bacillus coagulans</subject><subject>Biochemistry</subject><subject>Chains</subject><subject>Cytokines</subject><subject>Diet</subject><subject>Disease control</subject><subject>Fermentation</subject><subject>Fibrinogen</subject><subject>Freund's adjuvant</subject><subject>Glycoproteins</subject><subject>Immune response</subject><subject>Immune system</subject><subject>Immunomodulation</subject><subject>In vivo methods and tests</subject><subject>Indomethacin</subject><subject>Inflammatory diseases</subject><subject>Inulin</subject><subject>Mathematical models</subject><subject>Microbiota</subject><subject>Oral administration</subject><subject>Original</subject><subject>Parameters</subject><subject>Prebiotics</subject><subject>Pretreatment</subject><subject>Probiotics</subject><subject>Rheumatoid arthritis</subject><subject>Rodents</subject><subject>Spores</subject><subject>Tumor necrosis factor-α</subject><issn>1654-6628</issn><issn>1654-661X</issn><issn>1654-661X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>DOA</sourceid><recordid>eNptkkuLFDEURgtRnHF06VYCbtzUmFcllY2gg4-BATcjuAu38uhOU5W0SVVLb_ztpqfHxhFXuUlODjeXr2leEnzJOKZvfcyXO1E3uJfiUXNORMdbIcj3x6ea9mfNs1I2GItK8afNGZWcSqL4efPrdu2Q896ZuaDkUcowjnsEdgoxlNllZ9EHMGEcl4JMgtUyQiwIokUhLmOIKEW0zW7n4hxqebjY5rTKrpTDvirz2i0TzClYBHle5zCHUh-jDHN53jzxMBb34n69aL59-nh79aW9-fr5-ur9TWu4InNb22PU-Z5b6R3v-ACDUopQKYkENhjsiXCgsLIgrcWUMGo7DJ3osTFYOXbRXB-9NsFGb3OYIO91gqDvDlJe6dpbMKPTAnfKDoT3ngHv6NADlcwxRTsKTmFbXe-Oru0yTM6a-vM6tAfShzcxrPUq7TRXXPaMV8Gbe0FOPxZXZj2FYtxYJ-vSUjTpccd7IaWq6Ot_0E1acqyj0pSSjjKmhKhUe6RMTqVk50_NEKwPKdE1JbqmRN-lpPKv_v7Bif4Tiwr0RyBEn_IEP1MerZ5hP6bsM0QTimb_d_8G0D_PJg</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Abhari, Khadijeh</creator><creator>Shekarforoush, Seyed Shahram</creator><creator>Hosseinzadeh, Saeid</creator><creator>Nazifi, Saeid</creator><creator>Sajedianfard, Javad</creator><creator>Eskandari, Mohammad Hadi</creator><general>Taylor & Francis</general><general>Swedish Nutrition Foundation, SNF</general><general>Co-Action Publishing</general><general>Swedish Nutrition Foundation</general><scope>0YH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7T7</scope><scope>7TS</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0K</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20160101</creationdate><title>The effects of orally administered Bacillus coagulans and inulin on prevention and progression of rheumatoid arthritis in rats</title><author>Abhari, Khadijeh ; Shekarforoush, Seyed Shahram ; Hosseinzadeh, Saeid ; Nazifi, Saeid ; Sajedianfard, Javad ; Eskandari, Mohammad Hadi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c491t-fec32ef84d7fe454bab999127717a3bc0f16ea909da7dd02132d50a5680cc09e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Amyloid</topic><topic>animal model</topic><topic>Arthritis</topic><topic>Bacillus coagulans</topic><topic>Biochemistry</topic><topic>Chains</topic><topic>Cytokines</topic><topic>Diet</topic><topic>Disease control</topic><topic>Fermentation</topic><topic>Fibrinogen</topic><topic>Freund's adjuvant</topic><topic>Glycoproteins</topic><topic>Immune response</topic><topic>Immune system</topic><topic>Immunomodulation</topic><topic>In vivo methods and tests</topic><topic>Indomethacin</topic><topic>Inflammatory diseases</topic><topic>Inulin</topic><topic>Mathematical models</topic><topic>Microbiota</topic><topic>Oral administration</topic><topic>Original</topic><topic>Parameters</topic><topic>Prebiotics</topic><topic>Pretreatment</topic><topic>Probiotics</topic><topic>Rheumatoid arthritis</topic><topic>Rodents</topic><topic>Spores</topic><topic>Tumor necrosis factor-α</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abhari, Khadijeh</creatorcontrib><creatorcontrib>Shekarforoush, Seyed Shahram</creatorcontrib><creatorcontrib>Hosseinzadeh, Saeid</creatorcontrib><creatorcontrib>Nazifi, Saeid</creatorcontrib><creatorcontrib>Sajedianfard, Javad</creatorcontrib><creatorcontrib>Eskandari, Mohammad Hadi</creatorcontrib><collection>Taylor & Francis Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Physical Education Index</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Food & nutrition research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abhari, Khadijeh</au><au>Shekarforoush, Seyed Shahram</au><au>Hosseinzadeh, Saeid</au><au>Nazifi, Saeid</au><au>Sajedianfard, Javad</au><au>Eskandari, Mohammad Hadi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effects of orally administered Bacillus coagulans and inulin on prevention and progression of rheumatoid arthritis in rats</atitle><jtitle>Food & nutrition research</jtitle><addtitle>Food Nutr Res</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>60</volume><issue>1</issue><spage>30876</spage><epage>30876</epage><pages>30876-30876</pages><issn>1654-6628</issn><issn>1654-661X</issn><eissn>1654-661X</eissn><abstract>Probiotics have been considered as an approach to addressing the consequences of different inflammatory disorders. The spore-forming probiotic strain Bacillus coagulans has demonstrated anti-inflammatory and immune-modulating effects in both animals and humans. The prebiotic inulin also potentially affects the immune system as a result of the change in the composition or fermentation profile of the gastrointestinal microbiota.
In the present study, an in vivo model was conducted to investigate the possible influences of probiotic B. coagulans and prebiotic inulin, both in combination and/or separately, on the downregulation of immune responses and the progression of rheumatoid arthritis (RA), using arthritis-induced rat model.
Forty-eight healthy male Wistar rats were randomly categorized into six experimental groups as follows: 1) control: normal healthy rats fed with standard diet, 2) disease control (RA): arthritis-induced rats fed with standard diet, 3) prebiotic (PRE): RA+ 5% w/w long-chain inulin, 4) probiotic (PRO): RA+ 10
9
spores/day B. coagulans by orogastric gavage, 5) synbiotic (SYN): RA+ 5% w/w long-chain inulin and 10
9
spores/day B. coagulans, and 6) treatment control: (INDO): RA+ 3 mg/kg/day indomethacin by orogastric gavage. Feeding with the listed diets started on day 0 and continued to the end of study. On day 14, rats were injected with complete Freund's adjuvant (CFA) to induce arthritis. Arthritis activity was evaluated by the biochemical parameters and paw thickness. Biochemical assay for fibrinogen (Fn), serum amyloid A (SAA), and TNF-α and alpha-1-acid glycoprotein (α
1
AGp) was performed on day 21, 28, and 35 (7, 14 and 21 days post RA induction), respectively.
Pretreatment with PRE, PRO, and SYN diets significantly inhibits SAA and Fn production in arthritic rats (P < 0.001). A significant decrease in the production of pro-inflammatory cytokines, such as TNF-α, was seen in the PRE, PRO, and SYN groups (P < 0.001), which was similar to the anti-inflammatory effect of indomethacin. Furthermore, no significant anti-inflammatory effects were observed following different treatments using α
1
AGp as an RA indicator. Pretreatment with all supplied diets significantly inhibited the development of paw swelling induced by CFA (P < 0.001).
The results of this study indicate that the oral intake of probiotic B. coagulans and prebiotic inulin can improve the biochemical and clinical parameters of induced RA in rat.</abstract><cop>Sweden</cop><pub>Taylor & Francis</pub><pmid>27427194</pmid><doi>10.3402/fnr.v60.30876</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1654-6628 |
ispartof | Food & nutrition research, 2016-01, Vol.60 (1), p.30876-30876 |
issn | 1654-6628 1654-661X 1654-661X |
language | eng |
recordid | cdi_crossref_primary_10_3402_fnr_v60_30876 |
source | Taylor & Francis Open Access; DOAJ Directory of Open Access Journals; Co-Action Open Access Journals; Norart Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Amyloid animal model Arthritis Bacillus coagulans Biochemistry Chains Cytokines Diet Disease control Fermentation Fibrinogen Freund's adjuvant Glycoproteins Immune response Immune system Immunomodulation In vivo methods and tests Indomethacin Inflammatory diseases Inulin Mathematical models Microbiota Oral administration Original Parameters Prebiotics Pretreatment Probiotics Rheumatoid arthritis Rodents Spores Tumor necrosis factor-α |
title | The effects of orally administered Bacillus coagulans and inulin on prevention and progression of rheumatoid arthritis in rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T14%3A43%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effects%20of%20orally%20administered%20Bacillus%20coagulans%20and%20inulin%20on%20prevention%20and%20progression%20of%20rheumatoid%20arthritis%20in%20rats&rft.jtitle=Food%20&%20nutrition%20research&rft.au=Abhari,%20Khadijeh&rft.date=2016-01-01&rft.volume=60&rft.issue=1&rft.spage=30876&rft.epage=30876&rft.pages=30876-30876&rft.issn=1654-6628&rft.eissn=1654-661X&rft_id=info:doi/10.3402/fnr.v60.30876&rft_dat=%3Cproquest_cross%3E2215233966%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2215233966&rft_id=info:pmid/27427194&rft_doaj_id=oai_doaj_org_article_6059db148f3a452b8a273e39252ae90d&rfr_iscdi=true |